Associated Banc Corp Has $1.48 Million Stock Position in Roche Holding AG $RHHBY

Associated Banc Corp lessened its holdings in Roche Holding AG (OTCMKTS:RHHBY) by 4.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 36,375 shares of the company’s stock after selling 1,620 shares during the period. Associated Banc Corp’s holdings in Roche were worth $1,476,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Boston Common Asset Management LLC grew its holdings in shares of Roche by 11.1% during the 2nd quarter. Boston Common Asset Management LLC now owns 361,833 shares of the company’s stock valued at $14,682,000 after acquiring an additional 36,101 shares in the last quarter. Corient IA LLC bought a new position in shares of Roche during the 1st quarter valued at $616,000. FCA Corp TX bought a new position in Roche during the first quarter valued at about $494,000. Everett Harris & Co. CA bought a new stake in Roche during the first quarter worth approximately $445,000. Finally, Rhumbline Advisers raised its position in shares of Roche by 7.4% in the first quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock valued at $4,413,000 after purchasing an additional 7,374 shares during the period.

Roche Trading Up 2.2%

Shares of OTCMKTS:RHHBY opened at $48.63 on Wednesday. Roche Holding AG has a one year low of $34.10 and a one year high of $49.20. The company has a 50 day moving average of $43.66 and a 200-day moving average of $41.44.

Analysts Set New Price Targets

Several research analysts have commented on RHHBY shares. HSBC raised Roche from a “hold” rating to a “buy” rating and set a $50.00 price target on the stock in a research report on Thursday, October 2nd. Hsbc Global Res raised shares of Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 2nd. Morgan Stanley reiterated an “underweight” rating on shares of Roche in a research note on Wednesday, October 29th. Jefferies Financial Group lowered Roche from a “hold” rating to a “moderate sell” rating in a report on Monday, October 27th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Roche from a “sell” rating to a “hold” rating in a research note on Tuesday, November 11th. Three investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $50.00.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.